In This Section
Kimberly Stegmaier, MD

Kimberly Stegmaier, MD

Dana-Farber Cancer Institute
Boston, Massachusetts

Class of 2026

For fundamental and innovative research in pediatric oncology, including the integration of functional genomics and chemical biology to define fusion gene-driven oncogenic mechanisms, systematically mapping context-specific dependencies, and translating these discoveries into multi-institutional clinical trials to establish new precision cancer therapies for children with cancer.

*Full-length biography in development

[Institutional affiliations listed for Fellows reflect those held at the time of their induction into the AACR Academy.]